What We're Reading
Industry reads hand-picked by our editors
Nov 30, 2022
Nov 29, 2022
-
The Wall Street Journal
Nestlé May Shed Peanut Allergy Treatment as Sales Disappoint
-
Financial Times
Japan’s Eisai aims to silence critics over breakthrough Alzheimer’s drug
-
Bloomberg
China Aims to Boost Elderly Covid Vaccination Amid Reopening Pressure
-
Axios
Standalone drug plans broached for frail seniors in community-based care
Nov 28, 2022
Nov 23, 2022
Nov 22, 2022
-
Reuters
U.S. midterms dampen Big Pharma hopes for drug price policy change
-
The Wall Street Journal
Japan Approves First Homegrown Covid-19 Antiviral Pill
-
C&EN
Birth control for men
Nov 21, 2022
-
Financial Times
Bristol Myers Squibb warns US price reforms will dent drug development
-
Stat News
Biosplice, once the most valuable biotech startup, sees a pair of osteoarthritis trials fail
-
FierceBiotech
Lysogene’s lead gene therapy fails Phase 2/3 trial with cash low
-
CNBC
Theranos founder Elizabeth Holmes sentenced to over 11 years in prison
Nov 18, 2022
-
The New York Times
The End of Covid Vaccines at ‘Warp Speed’
-
Evaluate Vantage
Pulling back the curtain on Astrazeneca’s Car-T work
-
Axios
Get ready for a drug importation revival
